A retrospective analysis of the change in anti-malarial treatment policy: Peru

被引:18
|
作者
Williams, Holly Ann [1 ,5 ]
Vincent-Mark, Arlene [2 ,5 ]
Herrera, Yenni [3 ]
Chang, O. Jaime [4 ]
机构
[1] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30341 USA
[2] CDC, Div Injury Response, Atlanta, GA 30333 USA
[3] Minist Salud, Jesus Maria Lima, Peru
[4] USAID, Lima, Peru
[5] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA
关键词
MALARIA-TREATMENT POLICY; DRUG POLICY; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE; LESSONS;
D O I
10.1186/1475-2875-8-85
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: National malaria control programmes must deal with the complex process of changing national malaria treatment guidelines, often without guidance on the process of change. Selecting a replacement drug is only one issue in this process. There is a paucity of literature describing successful malaria treatment policy changes to help guide control programs through this process. Objectives: To understand the wider context in which national malaria treatment guidelines were formulated in a specific country (Peru). Methods: Using qualitative methods (individual and focus group interviews, stakeholder analysis and a review of documents), a retrospective analysis of the process of change in Peru's anti-malarial treatment policy from the early 1990's to 2003 was completed. Results: The decision to change Peru's policies resulted from increasing levels of anti-malarial drug resistance, as well as complaints from providers that the drugs were no longer working. The context of the change occurred in a time in which Peru was changing national governments, which created extreme challenges in moving the change process forward. Peru utilized a number of key strategies successfully to ensure that policy change would occur. This included a) having the process directed by a group who shared a common interest in malaria and who had long-established social and professional networks among themselves, b) engaging in collaborative teamwork among nationals and between nationals and international collaborators, c) respect for and inclusion of district-level staff in all phases of the process, d) reliance on high levels of technical and scientific knowledge, e) use of standardized protocols to collect data, and f) transparency. Conclusion: Although not perfectly or fully implemented by 2003, the change in malaria treatment policy in Peru occurred very quickly, as compared to other countries. They identified a problem, collected the data necessary to justify the change, utilized political will to their favor, approved the policy, and moved to improve malaria control in their country. As such, they offer an excellent example for other countries as they contemplate or embark on policy changes.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Anti-malarial market and policy surveys in sub-Saharan Africa
    Diap, Graciela
    Amuasi, John
    Boakye, Isaac
    Sevcsik, Ann-Marie
    Pecoul, Bernard
    MALARIA JOURNAL, 2010, 9
  • [22] Anti-malarial market and policy surveys in sub-Saharan Africa
    Graciela Diap
    John Amuasi
    Isaac Boakye
    Ann-Marie Sevcsik
    Bernard Pecoul
    Malaria Journal, 9
  • [23] Adherence to Anti-Malarial Treatment in Malaria Endemic Areas of Bangladesh
    Hossain, Mohammad Sharif
    Matin, Mohammad Abdul
    Ferdous, Nur-E Naznin
    Hasan, Anamul
    Sazed, Saiful Arefeen
    Neogi, Amit Kumer
    Chakma, Sumit
    Islam, Md. Atiqul
    Khan, Afsana Alamgir
    Haque, Md. Ekramul
    Islam, Shayla
    Islam, Md. Nazmul
    Khan, Wasif Ali
    Islam, Md. Akramul
    Haque, Rashidul
    Alam, Mohammad Shafiul
    Tsuji, Moriya
    PATHOGENS, 2023, 12 (12):
  • [24] Repurposing of Anti-Malarial Drug Quinacrine for Cancer Treatment: A Review
    Kumar, Makhan
    Sarkar, Angshuman
    SCIENTIA PHARMACEUTICA, 2022, 90 (01)
  • [25] Immunity as a predictor of anti-malarial treatment failure: a systematic review
    Katherine O’Flaherty
    Julia Maguire
    Julie A. Simpson
    Freya J. I. Fowkes
    Malaria Journal, 16
  • [26] SELECTION FOR RESISTANCE FOLLOWING A VARIETY OF ANTI-MALARIAL TREATMENT REGIMES
    Huijben, Silvie
    Chan, Brian
    Sim, Derek
    Tomasello, Danielle
    Read, Andrew
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 380 - 380
  • [27] Immunity as a predictor of anti-malarial treatment failure: a systematic review
    O'Flaherty, Katherine
    Maguire, Julia
    Simpson, Julie A.
    Fowkes, Freya J. I.
    MALARIA JOURNAL, 2017, 16
  • [28] New trends in anti-malarial agents
    Frédérich, M
    Dogné, JM
    Angenot, L
    De Mol, P
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (15) : 1435 - 1456
  • [29] INFLUENCE OF DRYNESS ON ANTI-MALARIAL IMMUNITY
    MONJOUR, L
    RICHARDLENOBLE, D
    DRUILHE, P
    GENTILINI, M
    NOUVELLE PRESSE MEDICALE, 1978, 7 (19): : 1651 - 1651
  • [30] ANTI-MALARIAL ACTIVITY OF METHYLATION INHIBITORS
    WHAUN, JM
    CHIANG, PK
    JOURNAL OF PROTOZOOLOGY, 1983, 30 (03): : A19 - A20